Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.16 trillion and total revenue of $111.58 billion.
Market Cap
1.16T
Revenue
111.58B
Profits
-40.96B
PE Ratio
n/a
Profit Margin
-36.71%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.99B | 1.06% | 1,194,245 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.24B | -0.49% | 879,328 | 14.92B |
| 3 | ARGX | argenx SE | 50.04B | -1.24% | 381,572 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.92B | -0.19% | 976,700 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.19B | 0.47% | 181,558 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.88B | 2.90% | 1,844,515 | - |
| 7 | RPRX | Royalty Pharma plc | 30.66B | 3.00% | 4,153,223 | 2.44B |
| 8 | INSM | Insmed Incorporated | 25.57B | 1.72% | 6,728,248 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.32B | -1.53% | 879,891 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.91B | -0.58% | 5,702,856 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 20.01B | -5.35% | 7,508,264 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.74B | -0.31% | 1,630,366 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.20B | -1.99% | 1,975,388 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.13B | 2.50% | 432,458 | 998.25M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.58B | -0.84% | 2,207,467 | - |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.58B | 1.97% | 920,725 | 4.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.44B | 4.03% | 3,144,376 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.89B | 3.70% | 3,238,614 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.82B | 2.33% | 1,360,290 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.11B | 5.04% | 815,539 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.96B | 1.69% | 374,898 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.97B | -1.47% | 2,120,789 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.35B | 1.27% | 2,039,790 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.73B | 0.43% | 730,140 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.67B | 1.06% | 431,093 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.61B | 3.22% | 2,214,668 | 105.82M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.21B | 0.73% | 319,859 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.54B | 0.37% | 10,542,917 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.31B | 2.62% | 400,986 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.31B | -1.27% | 2,643,471 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.83B | 0.41% | 1,423,838 | - |
| 32 | KYMR | Kymera Therapeutics, Inc. | 7.04B | 2.44% | 408,524 | 51.48M |
| 33 | TECH | Bio-Techne Corporation | 7.03B | -5.34% | 3,904,885 | 1.21B |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.68B | 3.93% | 517,045 | 74.06M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.66B | 2.13% | 6,564,500 | 569.61M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.63B | 1.69% | 776,722 | - |
| 37 | CGON | CG Oncology, Inc. | 6.53B | 2.68% | 729,263 | 5.07M |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.42B | 2.64% | 1,128,592 | 217.17M |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.29B | 1.22% | 745,803 | - |
| 40 | CORT | Corcept Therapeutics Incorporated | 6.13B | 11.57% | 2,307,964 | 769.10M |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.08% | 1,791,756 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.09B | -2.08% | 1,240,516 | 827.11M |
| 43 | TGTX | TG Therapeutics, Inc. | 6.04B | 0.26% | 1,828,783 | 700.35M |
| 44 | BLTE | Belite Bio, Inc | 6.04B | -1.30% | 154,459 | - |
| 45 | CELC | Celcuity Inc. | 6.02B | -0.17% | 989,348 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 6.01B | 1.99% | 1,690,459 | - |
| 47 | IMVT | Immunovant, Inc. | 5.95B | 2.09% | 1,222,909 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.86B | -0.70% | 1,182,248 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.40B | 1.60% | 1,075,293 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.30B | 1.45% | 2,941,515 | 1.14B |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.07% | 68,611,410 | 1.11B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.09B | -0.15% | 923,019 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | -0.48% | 419,999 | 1.34M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.43B | -0.36% | 218,576 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.41B | 3.12% | 341,836 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.34B | -2.93% | 1,749,736 | 22.57M |
| 57 | CAI | Caris Life Sciences, Inc. | 4.15B | -12.35% | 6,969,894 | 907.29M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.14B | 3.99% | 2,545,582 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.54% | 1,174,373 | 18.07M |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.06% | 2,865,783 | 596.96M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 2.12% | 1,543,120 | 1.10B |
| 62 | ORKA | Oruka Therapeutics, Inc. | 3.78B | -2.27% | 947,376 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.68B | 1.21% | 2,275,676 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.68B | 8.55% | 3,301,589 | 56.99M |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.63B | -0.74% | 1,130,641 | - |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.58B | 1.25% | 75,831 | 803.79M |
| 67 | ERAS | Erasca, Inc. | 3.25B | 0.77% | 4,339,670 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.17B | 0.85% | 2,823,637 | 164.01M |
| 69 | ALMS | Alumis Inc. | 3.16B | 5.74% | 841,607 | 24.05M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.14B | 0.40% | 637,678 | 236.00M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.14B | 1.75% | 1,257,701 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.05B | 0.38% | 979,944 | - |
| 73 | VERA | Vera Therapeutics, Inc. | 2.81B | 6.68% | 1,186,037 | - |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 2.78B | 8.07% | 1,264,693 | 535.08M |
| 75 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | 1,396,430 | 285.01M |
| 76 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -5.34% | 349,492 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.71B | 4.83% | 3,663,265 | 415.62M |
| 78 | GPCR | Structure Therapeutics Inc. | 2.71B | 0.63% | 458,229 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.68B | 2.31% | 766,248 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.65B | 2.98% | 1,065,949 | - |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | -1.42% | 1,363,135 | 670.00M |
| 82 | NKTR | Nektar Therapeutics | 2.56B | -3.16% | 686,844 | 55.63M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.55B | 1.59% | 1,157,098 | 865.00K |
| 84 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | 2.77% | 978,275 | 225.27M |
| 85 | RLAY | Relay Therapeutics, Inc. | 2.53B | 2.24% | 2,310,579 | 10.68M |
| 86 | IMNM | Immunome, Inc. | 2.51B | -2.16% | 1,030,477 | 4.02M |
| 87 | NBTX | Nanobiotix S.A. | 2.50B | 7.88% | 54,031 | 38.27M |
| 88 | KOD | Kodiak Sciences Inc. | 2.47B | 0.30% | 401,541 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.40B | 4.02% | 1,483,684 | - |
| 90 | ZLAB | Zai Lab Limited | 2.30B | 4.81% | 821,176 | 453.28M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | -8.20% | 1,630,120 | - |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 3.46% | 2,144,510 | - |
| 93 | PHVS | Pharvaris N.V. | 2.15B | 5.41% | 205,071 | - |
| 94 | TYRA | Tyra Biosciences, Inc. | 2.15B | 3.79% | 644,213 | - |
| 95 | GENB | Generate Biomedicines, Inc. | 2.07B | 4.71% | 483,614 | 30.30M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.25% | 1,393,665 | 298.30M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 0.87% | 2,777,243 | 52.04M |
| 98 | NTLA | Intellia Therapeutics, Inc. | 2.00B | 2.07% | 3,756,578 | 66.09M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | -1.52% | 3,415,231 | 2.18B |
| 100 | STOK | Stoke Therapeutics, Inc. | 1.97B | -2.43% | 837,998 | 32.08M |
| 101 | ADMA | ADMA Biologics, Inc. | 1.97B | 1.07% | 4,267,648 | 509.86M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.95B | 5.32% | 529,640 | - |
| 103 | TSHA | Taysha Gene Therapies, Inc. | 1.92B | -2.63% | 3,497,521 | 7.47M |
| 104 | AAPG | Ascentage Pharma Group International | 1.92B | 1.04% | 3,605 | 82.08M |
| 105 | MESO | Mesoblast Limited | 1.91B | 2.01% | 159,748 | 65.38M |
| 106 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 2.96% | 378,585 | 1.20B |
| 107 | OCS | Oculis Holding AG | 1.86B | 3.16% | 696,031 | 1.40M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 2.35% | 1,539,077 | 217.17M |
| 109 | QURE | uniQure N.V. | 1.84B | 0.24% | 1,808,034 | 18.09M |
| 110 | ANAB | AnaptysBio, Inc. | 1.82B | -4.41% | 844,562 | 232.39M |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.82B | 2.26% | 254,603 | 20.00M |
| 112 | ZYME | Zymeworks Inc. | 1.79B | 2.80% | 646,783 | 81.26M |
| 113 | MBX | MBX Biosciences, Inc. | 1.78B | 1.41% | 811,852 | - |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | 2.26% | 646,879 | 899.11M |
| 115 | VRDN | Viridian Therapeutics, Inc. | 1.76B | 1.07% | 2,218,747 | 70.92M |
| 116 | CAPR | Capricor Therapeutics, Inc. | 1.75B | -3.78% | 1,694,138 | 11.13M |
| 117 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -4.15% | 184,669 | - |
| 118 | INBX | Inhibrx Biosciences, Inc. | 1.72B | 8.56% | 568,851 | 1.30M |
| 119 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.23% | 747,367 | 66.05M |
| 120 | INVA | Innoviva, Inc. | 1.71B | 1.76% | 637,226 | 420.69M |
| 121 | VCEL | Vericel Corporation | 1.68B | -0.30% | 730,416 | 292.09M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.67B | 1.38% | 979,107 | 71.78M |
| 123 | NUVB | Nuvation Bio Inc. | 1.66B | -1.24% | 5,395,102 | 143.05M |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | 2.81% | 7,883,682 | 285.61M |
| 125 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -3.17% | 13,643,576 | 66.41M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | -0.78% | 740,096 | 42.95M |
| 127 | ARDX | Ardelyx, Inc. | 1.58B | -3.48% | 7,236,325 | 427.68M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.57B | -0.74% | 1,215,539 | 65.50M |
| 129 | ATAI | AtaiBeckley Inc. | 1.56B | 2.17% | 4,233,363 | 3.49M |
| 130 | NVAX | Novavax, Inc. | 1.52B | -4.05% | 5,174,306 | 596.34M |
| 131 | URGN | UroGen Pharma Ltd. | 1.51B | 3.83% | 936,623 | 140.49M |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.49B | 4.58% | 845,321 | 20.00M |
| 133 | IMCR | Immunocore Holdings plc | 1.47B | -1.19% | 145,856 | 412.81M |
| 134 | PGEN | Precigen, Inc. | 1.47B | 1.72% | 2,763,366 | 31.60M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.46B | 4.63% | 392,425 | - |
| 136 | ABCL | AbCellera Biologics Inc. | 1.46B | -3.64% | 5,954,518 | 79.21M |
| 137 | IMTX | Immatics N.V. | 1.45B | -5.27% | 1,524,141 | 43.00M |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.26% | 2,329,659 | 73.62M |
| 139 | MPLT | MapLight Therapeutics, Inc. | 1.39B | 1.22% | 190,201 | - |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.38B | -6.21% | 1,364,789 | - |
| 141 | FTRE | Fortrea Holdings Inc. | 1.37B | -0.96% | 958,507 | 2.71B |
| 142 | BHVN | Biohaven Ltd. | 1.36B | -1.85% | 2,417,484 | - |
| 143 | GHRS | GH Research PLC | 1.36B | 1.58% | 112,695 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.16% | 310,518 | - |
| 145 | WVE | Wave Life Sciences Ltd. | 1.34B | 2.95% | 7,305,725 | 71.80M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.34B | 1.21% | 1,188,090 | - |
| 147 | SVRA | Savara Inc. | 1.34B | 3.74% | 1,527,362 | - |
| 148 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | -0.81% | 1,150,341 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.29B | 3.11% | 402,321 | - |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 10.27% | 209,918 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.26B | 4.02% | 516,448 | 10.00M |
| 152 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.63% | 214,752 | - |
| 153 | SLS | SELLAS Life Sciences Group, Inc. | 1.21B | 25.10% | 30,684,197 | - |
| 154 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -2.79% | 1,271,226 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.17B | -2.40% | 196,256 | 5.74M |
| 156 | IVA | Inventiva S.A. | 1.16B | -3.65% | 106,482 | 7.94M |
| 157 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -6.22% | 2,144,289 | 204.73M |
| 158 | EYPT | EyePoint, Inc. | 1.13B | -1.40% | 838,320 | 7.61M |
| 159 | SEPN | Septerna, Inc. | 1.12B | -0.36% | 315,740 | 72.26M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.24% | 3,314,830 | 69.64M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.01% | 129,525 | 8.28M |
| 162 | OMER | Omeros Corporation | 1.04B | -2.57% | 2,377,106 | 9.89M |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 1.00B | 1.11% | 971,816 | - |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 997.64M | 0.24% | 1,154,271 | 204.89M |
| 165 | MNKD | MannKind Corporation | 991.73M | -2.13% | 4,510,656 | 360.78M |
| 166 | DSGN | Design Therapeutics, Inc. | 975.58M | -1.08% | 764,118 | - |
| 167 | PHAR | Pharming Group N.V. | 940.29M | -0.92% | 12,619 | 369.49M |
| 168 | LBRX | LB Pharmaceuticals Inc | 926.54M | 3.79% | 179,294 | - |
| 169 | MGTX | MeiraGTx Holdings plc | 922.96M | 1.84% | 365,937 | 81.39M |
| 170 | XNCR | Xencor, Inc. | 917.87M | -0.48% | 761,921 | 97.36M |
| 171 | GERN | Geron Corporation | 904.54M | 0.71% | 25,244,730 | 196.12M |
| 172 | ANNX | Annexon, Inc. | 892.94M | 0.18% | 2,253,381 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 890.98M | 1.39% | 845,508 | 13.73M |
| 174 | SANA | Sana Biotechnology, Inc. | 890.53M | -1.84% | 4,248,286 | - |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 890.25M | -2.60% | 1,621,515 | - |
| 176 | SPTX | Seaport Therapeutics, Inc. | 875.49M | 3.51% | 431,692 | - |
| 177 | VOR | Vor Biopharma Inc. | 862.10M | -3.40% | 692,005 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 859.39M | 1.15% | 370,681 | 109.78M |
| 179 | ABUS | Arbutus Biopharma Corporation | 848.81M | - | 1,189,130 | 191.45M |
| 180 | DRTS | Alpha Tau Medical Ltd. | 848.41M | -2.43% | 775,489 | - |
| 181 | ODTX | Odyssey Therapeutics, Inc. | 846.30M | 0.22% | 316,311 | 2.98M |
| 182 | KURA | Kura Oncology, Inc. | 841.58M | -2.07% | 2,427,528 | 71.64M |
| 183 | EVMN | Evommune, Inc. | 838.87M | 2.64% | 313,000 | 10.00M |
| 184 | AURA | Aura Biosciences, Inc. | 829.16M | 1.13% | 619,637 | - |
| 185 | ABSI | Absci Corporation | 826.30M | -1.12% | 3,481,428 | 1.84M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 825.09M | -2.32% | 3,019,209 | 35.54M |
| 187 | ALLO | Allogene Therapeutics, Inc. | 803.91M | 1.30% | 6,459,236 | 22.00K |
| 188 | DRUG | Bright Minds Biosciences Inc. | 803.33M | -0.08% | 147,125 | - |
| 189 | ANRO | Alto Neuroscience, Inc. | 800.95M | -7.23% | 416,747 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 796.22M | -1.33% | 20,327 | - |
| 191 | SPRY | ARS Pharmaceuticals, Inc. | 795.40M | -7.18% | 2,508,057 | 84.28M |
| 192 | RLMD | Relmada Therapeutics, Inc. | 785.61M | 0.54% | 1,043,329 | - |
| 193 | SLDB | Solid Biosciences Inc. | 726.56M | -4.40% | 1,607,966 | - |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 710.89M | 4.30% | 2,245,789 | 8.37M |
| 195 | TENX | Tenax Therapeutics, Inc. | 701.24M | -2.14% | 432,732 | - |
| 196 | EIKN | Eikon Therapeutics, Inc. | 666.45M | 6.76% | 449,730 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 665.19M | -0.27% | 29,983 | 117.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 657.36M | 0.63% | 924,692 | 122.29M |
| 199 | STRO | Sutro Biopharma, Inc. | 656.09M | -3.20% | 219,625 | 102.48M |
| 200 | CADL | Candel Therapeutics, Inc. | 655.04M | 2.52% | 1,824,379 | - |
| 201 | KYTX | Kyverna Therapeutics, Inc. | 652.52M | 5.38% | 1,840,123 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 651.62M | 6.23% | 251,894 | 11.88M |
| 203 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 646.67M | -0.62% | 284,702 | - |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 640.42M | 3.48% | 301,908 | - |
| 205 | ARVN | Arvinas, Inc. | 636.82M | 3.13% | 787,116 | 89.40M |
| 206 | FBRX | Forte Biosciences, Inc. | 625.41M | 1.52% | 126,467 | - |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 594.47M | 9.40% | 918,590 | 299.77M |
| 208 | PRME | Prime Medicine, Inc. | 590.62M | -0.91% | 2,441,631 | 4.03M |
| 209 | CRMD | CorMedix Inc. | 588.32M | -0.13% | 1,127,583 | 311.71M |
| 210 | CABA | Cabaletta Bio, Inc. | 585.35M | -1.10% | 5,869,979 | - |
| 211 | VALN | Valneva SE | 572.49M | -1.67% | 30,663 | 205.07M |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 561.14M | 3.00% | 1,228,636 | 151.40M |
| 213 | ANL | Adlai Nortye Ltd. | 557.60M | 6.01% | 42,110 | 5.00M |
| 214 | IMMX | Immix Biopharma, Inc. | 556.10M | -1.59% | 562,071 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 550.59M | -7.45% | 50,373 | - |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 546.29M | 1.06% | 362,759 | 88.24M |
| 217 | CLYM | Climb Bio, Inc. | 545.04M | 2.15% | 375,286 | - |
| 218 | TECX | Tectonic Therapeutic, Inc. | 543.62M | 3.04% | 222,373 | - |
| 219 | AVTX | Avalo Therapeutics, Inc. | 530.28M | -0.45% | 1,565,185 | 59.00K |
| 220 | CTNM | Contineum Therapeutics, Inc. | 529.02M | 3.59% | 92,499 | - |
| 221 | PROK | ProKidney Corp. | 528.43M | -1.69% | 631,634 | 893.00K |
| 222 | MDXG | MiMedx Group, Inc. | 524.29M | -0.56% | 1,978,326 | 389.42M |
| 223 | XOMA | XOMA Royalty Corporation | 524.22M | 0.12% | 74,386 | 48.56M |
| 224 | RGNX | REGENXBIO Inc. | 518.24M | -1.95% | 1,607,781 | 170.44M |
| 225 | NGNE | Neurogene Inc. | 515.46M | 3.42% | 135,988 | 925.00K |
| 226 | STTK | Shattuck Labs, Inc. | 510.18M | 1.96% | 327,982 | 1.00M |
| 227 | UPB | Upstream Bio, Inc. | 509.37M | 4.58% | 815,600 | 3.32M |
| 228 | ASMB | Assembly Biosciences, Inc. | 504.11M | 2.92% | 66,459 | 71.10M |
| 229 | PRTA | Prothena Corporation plc | 502.59M | 1.80% | 530,778 | 57.94M |
| 230 | OCGN | Ocugen, Inc. | 497.62M | - | 4,418,524 | 4.47M |
| 231 | OVID | Ovid Therapeutics Inc. | 484.50M | -2.44% | 1,830,890 | 7.12M |
| 232 | FULC | Fulcrum Therapeutics, Inc. | 483.09M | 4.17% | 535,712 | 80.00M |
| 233 | SGMT | Sagimet Biosciences Inc. | 469.31M | -0.65% | 775,847 | - |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 469.20M | -0.79% | 85,204 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 468.69M | 0.43% | 393,097 | 16.72M |
| 236 | ZURA | Zura Bio Limited | 455.43M | 1.05% | 321,810 | - |
| 237 | AUTL | Autolus Therapeutics plc | 455.11M | 6.87% | 1,996,015 | 75.39M |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 452.28M | 1.05% | 1,242,922 | - |
| 239 | LYEL | Lyell Immunopharma, Inc. | 448.92M | -0.05% | 39,433 | 31.00K |
| 240 | ADCT | ADC Therapeutics SA | 442.63M | 1.46% | 1,048,131 | 79.18M |
| 241 | REPL | Replimune Group, Inc. | 437.63M | 29.58% | 17,768,944 | - |
| 242 | PRTC | PureTech Health plc | 432.38M | 1.45% | 10,127 | 4.66M |
| 243 | LRMR | Larimar Therapeutics, Inc. | 425.92M | -0.73% | 822,744 | - |
| 244 | IVVD | Invivyd, Inc. | 415.72M | -1.34% | 1,962,736 | 53.43M |
| 245 | VSTM | Verastem, Inc. | 414.76M | 1.94% | 1,912,420 | 49.59M |
| 246 | MNPR | Monopar Therapeutics Inc. | 411.57M | 0.15% | 302,475 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 411.21M | -0.44% | 681,078 | 109.16M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 407.14M | -3.44% | 159,216 | 69.21M |
| 249 | CCCC | C4 Therapeutics, Inc. | 405.47M | 16.09% | 14,563,913 | 34.86M |
| 250 | BNTC | Benitec Biopharma Inc. | 399.07M | -1.60% | 72,237 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 398.97M | -2.53% | 245,393 | 9.01M |
| 252 | ALT | Altimmune, Inc. | 393.27M | -1.95% | 3,584,534 | 36.00K |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 393.10M | -1.10% | 1,673,054 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 392.95M | -1.39% | 42,976 | 17.00K |
| 255 | VNDA | Vanda Pharmaceuticals Inc. | 386.67M | 0.16% | 955,675 | 217.78M |
| 256 | NAUT | Nautilus Biotechnology, Inc. | 374.88M | 0.68% | 450,466 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 365.72M | -16.91% | 971,325 | - |
| 258 | YDES | YD Bio Limited | 365.66M | 0.19% | 15,293 | 510.36K |
| 259 | PBYI | Puma Biotechnology, Inc. | 364.95M | 1.27% | 246,639 | 227.18M |
| 260 | IRD | Opus Genetics, Inc. | 359.15M | -2.90% | 1,436,205 | 11.98M |
| 261 | CMPX | Compass Therapeutics, Inc. | 354.77M | 5.35% | 5,385,605 | 850.00K |
| 262 | GLSI | Greenwich LifeSciences, Inc. | 350.52M | 2.39% | 182,201 | - |
| 263 | IMRX | Immuneering Corporation | 348.07M | 3.86% | 499,481 | - |
| 264 | RZLT | Rezolute, Inc. | 347.87M | 0.91% | 1,440,787 | - |
| 265 | SRZN | Surrozen, Inc. | 346.21M | -1.70% | 68,405 | 7.49M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 337.31M | -0.95% | 124,416 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 330.41M | 0.42% | 238,899 | 63.50M |
| 268 | SLN | Silence Therapeutics plc | 329.70M | 2.80% | 56,515 | 839.00K |
| 269 | ABEO | Abeona Therapeutics Inc. | 325.44M | 0.53% | 2,501,204 | 14.54M |
| 270 | NMRA | Neumora Therapeutics, Inc. | 325.18M | -6.32% | 1,794,187 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 323.80M | -1.04% | 792,329 | 1.00 |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 323.65M | -2.00% | 26,041 | 4.90M |
| 273 | NVCT | Nuvectis Pharma, Inc. | 319.37M | 10.46% | 171,839 | - |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 319.10M | -3.76% | 1,708,566 | 14.78M |
| 275 | ACHV | Achieve Life Sciences, Inc. | 317.31M | -0.50% | 1,312,502 | - |
| 276 | PALI | Palisade Bio, Inc. | 313.08M | -2.60% | 1,868,313 | - |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 304.68M | - | 637,222 | 26.87M |
| 278 | CLLS | Cellectis S.A. | 301.58M | 1.64% | 29,330 | 75.11M |
| 279 | NAGE | Niagen Bioscience, Inc. | 300.09M | -2.34% | 1,253,814 | 130.42M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 299.93M | -0.51% | 1,419,470 | - |
| 281 | NGEN | NervGen Pharma Corp. | 294.59M | -2.41% | 134,396 | - |
| 282 | TARA | Protara Therapeutics, Inc. | 292.26M | 0.97% | 567,410 | - |
| 283 | OABI | OmniAb, Inc. | 291.39M | 8.65% | 1,174,669 | 28.94M |
| 284 | AVXL | Anavex Life Sciences Corp. | 285.43M | 0.65% | 866,114 | - |
| 285 | EDIT | Editas Medicine, Inc. | 283.93M | -1.02% | 925,880 | 38.69M |
| 286 | ACIU | AC Immune SA | 281.73M | 2.53% | 251,197 | 4.62M |
| 287 | SABS | SAB Biotherapeutics, Inc. | 278.29M | 9.39% | 757,279 | 114.70K |
| 288 | ALXO | ALX Oncology Holdings Inc. | 273.16M | - | 565,053 | - |
| 289 | CGEN | Compugen Ltd. | 269.48M | 0.71% | 131,937 | 72.76M |
| 290 | TRDA | Entrada Therapeutics, Inc. | 263.77M | 2.81% | 671,775 | 5.74M |
| 291 | CHRS | Coherus Oncology, Inc. | 263.00M | -0.29% | 2,407,283 | 46.88M |
| 292 | ARTV | Artiva Biotherapeutics, Inc. | 259.53M | -1.22% | 445,872 | 251.00K |
| 293 | HELP | Cybin Inc. | 259.19M | 2.37% | 423,235 | - |
| 294 | LENZ | LENZ Therapeutics, Inc. | 252.40M | 1.77% | 1,076,775 | 20.99M |
| 295 | HUMA | Humacyte, Inc. | 250.88M | 24.18% | 26,084,708 | 2.02M |
| 296 | VYGR | Voyager Therapeutics, Inc. | 250.75M | - | 418,741 | 36.49M |
| 297 | FATE | Fate Therapeutics, Inc. | 248.85M | -5.11% | 5,406,669 | 6.32M |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 247.39M | -3.22% | 120,244 | 1.78M |
| 299 | FHTX | Foghorn Therapeutics Inc. | 244.84M | -1.65% | 113,245 | 28.22M |
| 300 | ADAG | Adagene Inc. | 244.47M | 1.09% | 29,316 | 7.67M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 243.68M | 25.77% | 5,277,060 | 7.15M |
| 302 | NERV | Minerva Neurosciences, Inc. | 243.32M | -0.89% | 351,805 | - |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 243.12M | - | 192,097 | 32.72M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 240.12M | 9.29% | 14,718 | 19.39M |
| 305 | ALEC | Alector, Inc. | 238.70M | -0.46% | 459,225 | 18.42M |
| 306 | KROS | Keros Therapeutics, Inc. | 237.26M | 2.92% | 345,655 | 244.06M |
| 307 | NBP | NovaBridge Biosciences | 237.08M | -0.49% | 1,580,689 | - |
| 308 | FENC | Fennec Pharmaceuticals Inc. | 235.01M | -3.70% | 149,432 | 44.64M |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 234.77M | 0.12% | 386,167 | 54.71M |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 234.01M | -9.47% | 5,251,854 | 1.55M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 233.67M | - | 373,818 | 3.93M |
| 312 | CDXS | Codexis, Inc. | 227.24M | -1.57% | 846,989 | 78.09M |
| 313 | UNCY | Unicycive Therapeutics, Inc. | 227.22M | 4.16% | 669,711 | - |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 220.62M | 4.22% | 312,347 | 17.56M |
| 315 | MGNX | MacroGenics, Inc. | 219.28M | -1.99% | 1,634,629 | 149.50M |
| 316 | NKTX | Nkarta, Inc. | 218.93M | -6.71% | 886,230 | - |
| 317 | CNTX | Context Therapeutics Inc. | 216.83M | -4.84% | 449,195 | - |
| 318 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 215.50M | 6.30% | 316,096 | - |
| 319 | DTIL | Precision BioSciences, Inc. | 215.20M | 1.71% | 357,357 | 45.07M |
| 320 | MDWD | MediWound Ltd. | 208.85M | 0.74% | 53,972 | 16.96M |
| 321 | CRBU | Caribou Biosciences, Inc. | 208.31M | 4.43% | 1,670,966 | 11.20M |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 208.21M | -4.05% | 4,121,429 | 225.00K |
| 323 | ELTX | Elicio Therapeutics, Inc. | 207.88M | 7.11% | 220,354 | - |
| 324 | RNA | Atrium Therapeutics, Inc. | 206.35M | 1.22% | 100,721 | 18.62M |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 199.51M | -0.78% | 953,890 | 146.07M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 198.86M | 7.34% | 641,247 | - |
| 327 | TLSA | Tiziana Life Sciences Ltd | 191.44M | -3.85% | 279,834 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 184.43M | 2.47% | 183,521 | 2.00M |
| 329 | IFRX | InflaRx N.V. | 182.18M | 3.70% | 3,602,422 | 33.82K |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 179.85M | 0.40% | 178,329 | - |
| 331 | PRQR | ProQR Therapeutics N.V. | 179.11M | 6.25% | 626,017 | 15.73M |
| 332 | ENLV | Enlivex Ltd. | 176.54M | -2.26% | 249,518 | - |
| 333 | IMUX | Immunic, Inc. | 176.40M | 8.82% | 461,910 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 173.08M | -5.16% | 2,425,605 | 150.71M |
| 335 | PYXS | Pyxis Oncology, Inc. | 164.68M | 0.77% | 355,723 | 13.86M |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 163.88M | 1.06% | 503,876 | 70.00M |
| 337 | KRRO | Korro Bio, Inc. | 161.53M | -0.18% | 58,481 | 3.84M |
| 338 | KZIA | Kazia Therapeutics Limited | 159.98M | -2.10% | 82,002 | 1.27M |
| 339 | HURA | TuHURA Biosciences, Inc. | 159.58M | 3.72% | 400,236 | - |
| 340 | PLYX | Polaryx Therapeutics, Inc. | 159.31M | 2.59% | 86,798 | - |
| 341 | SPRB | Spruce Biosciences, Inc. | 155.52M | 1.55% | 49,317 | 697.00K |
| 342 | PLX | Protalix BioTherapeutics, Inc. | 155.50M | 1.05% | 2,202,417 | 76.38M |
| 343 | MENS | Jyong Biotech Ltd. | 155.34M | -3.35% | 32,896 | - |
| 344 | ANTX | AN2 Therapeutics, Inc. | 155.14M | 0.94% | 263,410 | - |
| 345 | GUTS | Fractyl Health, Inc. | 150.45M | 29.20% | 9,788,229 | 3.00K |
| 346 | MOLN | Molecular Partners AG | 150.18M | -0.99% | 4,261 | 856.30K |
| 347 | GALT | Galectin Therapeutics Inc. | 146.80M | -0.89% | 411,067 | - |
| 348 | EQ | Equillium, Inc. | 146.05M | 1.76% | 322,431 | 4.39M |
| 349 | AGEN | Agenus Inc. | 144.14M | 0.87% | 575,730 | 123.87M |
| 350 | AARD | Aardvark Therapeutics, Inc. | 143.77M | 7.86% | 172,671 | - |
| 351 | GNLX | Genelux Corporation | 141.66M | 7.41% | 279,947 | 8.00K |
| 352 | SPRO | Spero Therapeutics, Inc. | 141.28M | -3.94% | 675,027 | 66.80M |
| 353 | ALPS | Alps Group Inc | 139.79M | 0.31% | 4,330 | 3.74M |
| 354 | CNTB | Connect Biopharma Holdings Limited | 138.48M | -8.58% | 210,487 | 233.00K |
| 355 | OKUR | OnKure Therapeutics, Inc. | 137.34M | 0.29% | 185,483 | - |
| 356 | NTHI | NeOnc Technologies Holdings, Inc. | 136.53M | -1.63% | 71,222 | 39.99K |
| 357 | EDSA | Edesa Biotech, Inc. | 135.42M | 14.85% | 271,925 | - |
| 358 | IPHA | Innate Pharma S.A. | 134.92M | -2.94% | 9,154 | 10.57M |
| 359 | ACOG | Alpha Cognition Inc. | 129.55M | 8.38% | 45,853 | 10.22M |
| 360 | VRCA | Verrica Pharmaceuticals Inc. | 126.61M | 3.08% | 248,701 | 37.16M |
| 361 | PEPG | PepGen Inc. | 123.12M | 5.95% | 1,415,927 | - |
| 362 | TTRX | Turn Therapeutics Inc. | 119.45M | 0.75% | 40,436 | - |
| 363 | CRDF | Cardiff Oncology, Inc. | 115.55M | 3.05% | 672,652 | 593.00K |
| 364 | KLRS | Kalaris Therapeutics, Inc. | 111.63M | 1.36% | 119,522 | - |
| 365 | CBUS | Cibus, Inc. | 110.99M | 1.75% | 90,208 | 3.64M |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 109.80M | -4.96% | 3,505,015 | 65.34K |
| 367 | CGTX | Cognition Therapeutics, Inc. | 107.22M | 1.69% | 796,406 | - |
| 368 | BMEA | Biomea Fusion, Inc. | 107.00M | -6.33% | 917,360 | - |
| 369 | COYA | Coya Therapeutics, Inc. | 106.50M | 5.83% | 273,639 | 7.94M |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 104.80M | -4.55% | 894,412 | 1.63M |
| 371 | ENGN | enGene Therapeutics Inc. | 103.16M | 6.94% | 2,503,089 | - |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 102.55M | -0.58% | 1,331,305 | - |
| 373 | ONCY | Oncolytics Biotech Inc. | 101.15M | -3.58% | 562,133 | - |
| 374 | QTTB | Q32 Bio Inc. | 100.72M | 2.24% | 182,332 | 53.74M |
| 375 | VANI | Vivani Medical, Inc. | 100.03M | 1.75% | 102,912 | - |
| 376 | SEER | Seer, Inc. | 99.86M | -2.75% | 358,620 | 16.58M |
| 377 | NRXP | NRx Pharmaceuticals, Inc. | 97.45M | 2.79% | 757,482 | 1.23M |
| 378 | ANIX | Anixa Biosciences, Inc. | 97.23M | -1.69% | 98,811 | - |
| 379 | LONA | LeonaBio, Inc. | 96.94M | 1.47% | 22,849 | - |
| 380 | CUE | Cue Biopharma, Inc. | 95.94M | 0.72% | 130,504 | 27.47M |
| 381 | PMN | ProMIS Neurosciences, Inc. | 94.79M | 0.76% | 8,761 | - |
| 382 | NRXS | NeurAxis, Inc. | 91.01M | -4.35% | 174,600 | 4.28M |
| 383 | RNTX | Rein Therapeutics Inc. | 90.53M | 3.57% | 525,502 | - |
| 384 | ATRA | Atara Biotherapeutics, Inc. | 89.21M | 6.83% | 746,620 | 23.14M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 87.28M | -4.52% | 44,257 | 16.80M |
| 386 | OKYO | OKYO Pharma Limited | 85.02M | - | 17,276 | - |
| 387 | ACET | Adicet Bio, Inc. | 84.74M | 1.51% | 45,677 | - |
| 388 | EXOZ | eXoZymes, Inc. | 83.77M | - | 597 | -700.00 |
| 389 | CSBR | Champions Oncology, Inc. | 83.60M | -3.99% | 13,227 | 57.95M |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 82.18M | 1.59% | 162,325 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 80.64M | 0.88% | 3,320,201 | 48.47M |
| 392 | PYPD | PolyPid Ltd. | 80.53M | -7.46% | 127,978 | - |
| 393 | ATHE | Alterity Therapeutics Limited | 78.51M | -4.35% | 13,898 | 4.43M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 78.27M | -1.53% | 348,551 | - |
| 395 | ANVS | Annovis Bio, Inc. | 76.92M | -2.63% | 656,359 | - |
| 396 | XBIT | XBiotech Inc. | 76.22M | - | 32,665 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 75.92M | -1.11% | 284,139 | - |
| 398 | RLYB | Rallybio Corporation | 75.91M | 2.28% | 150,663 | 858.00K |
| 399 | ICCC | ImmuCell Corporation | 75.63M | -0.24% | 17,977 | 27.64M |
| 400 | OSTX | OS Therapies Incorporated | 75.25M | 4.68% | 535,078 | - |
| 401 | MCRB | Seres Therapeutics, Inc. | 74.75M | -2.51% | 35,440 | 1.15M |
| 402 | PDSB | PDS Biotechnology Corporation | 74.23M | 20.91% | 1,422,717 | - |
| 403 | FBIO | Fortress Biotech, Inc. | 74.08M | -1.33% | 349,463 | 63.26M |
| 404 | PLRX | Pliant Therapeutics, Inc. | 72.44M | -0.85% | 171,740 | - |
| 405 | ACTU | Actuate Therapeutics, Inc. | 70.42M | 2.77% | 95,634 | - |
| 406 | TCRX | TScan Therapeutics, Inc. | 69.72M | 0.87% | 357,157 | 9.14M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 68.79M | -9.15% | 985,708 | - |
| 408 | MNOV | MediciNova, Inc. | 67.43M | -0.72% | 12,207 | 409.66K |
| 409 | IMA | ImageneBio, Inc. | 64.54M | 0.87% | 276,801 | 800.00K |
| 410 | IMMP | Immutep Limited | 63.15M | -1.34% | 584,496 | 5.28M |
| 411 | IBO | Impact BioMedical Inc. | 62.73M | -6.91% | 61,273 | 39.00K |
| 412 | HYFT | MindWalk Holdings Corp. | 62.58M | -1.56% | 124,944 | 20.70M |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 62.13M | 9.41% | 165,350 | - |
| 414 | CING | Cingulate Inc. | 60.27M | 2.71% | 374,411 | - |
| 415 | ENTX | Entera Bio Ltd. | 60.14M | 3.20% | 64,842 | 42.00K |
| 416 | BYSI | BeyondSpring Inc. | 59.62M | 4.32% | 44,334 | 1.88M |
| 417 | FLNA | Filana Therapeutics, Inc. | 59.42M | 2.50% | 373,748 | - |
| 418 | LIXT | Lixte Biotechnology Holdings, Inc. | 58.09M | -1.38% | 40,899 | - |
| 419 | KALA | KALA BIO, Inc. | 56.88M | -1.92% | 79,925 | - |
| 420 | IBIO | iBio, Inc. | 56.02M | -3.73% | 644,752 | 300.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 55.05M | -3.16% | 33,882 | - |
| 422 | TIL | Instil Bio, Inc. | 54.93M | - | 35,287 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 51.95M | 2.22% | 198,002 | 22.33M |
| 424 | ESLA | Estrella Immunopharma, Inc. | 51.20M | -0.83% | 24,567 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 49.72M | 2.04% | 464,357 | 813.46K |
| 426 | RADX | Radiopharm Theranostics Limited | 48.91M | 8.65% | 67,132 | 10.86M |
| 427 | XLO | Xilio Therapeutics, Inc. | 46.43M | 0.39% | 23,044 | 53.48M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 44.43M | - | 31,975 | - |
| 429 | NTRB | Nutriband Inc. | 43.21M | -2.60% | 2,013 | 2.04M |
| 430 | LITS | Lite Strategy, Inc. | 42.91M | -5.60% | 309,560 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 42.29M | -2.38% | 104,220 | - |
| 432 | MREO | Mereo BioPharma Group plc | 41.42M | 5.49% | 1,333,533 | 500.00K |
| 433 | DARE | Daré Bioscience, Inc. | 41.35M | 7.98% | 527,897 | 1.03M |
| 434 | ALGS | Aligos Therapeutics, Inc. | 41.28M | 3.09% | 120,600 | 4.71M |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 40.22M | -0.77% | 73,386 | 90.00K |
| 436 | PSTV | Plus Therapeutics, Inc. | 39.11M | -2.56% | 112,873 | 5.21M |
| 437 | ATYR | aTyr Pharma, Inc. | 38.82M | -25.33% | 13,336,688 | 190.00K |
| 438 | INMB | INmune Bio Inc. | 38.81M | 5.04% | 209,067 | 50.00K |
| 439 | RNXT | RenovoRx, Inc. | 38.23M | -2.77% | 175,514 | 1.12M |
| 440 | NNVC | NanoViricides, Inc. | 37.14M | 14.67% | 521,853 | - |
| 441 | TVRD | Tvardi Therapeutics, Inc. | 37.06M | -0.75% | 25,246 | - |
| 442 | VERU | Veru Inc. | 36.27M | -0.44% | 58,128 | 16.89M |
| 443 | NXTC | NextCure, Inc. | 35.35M | 0.20% | 8,471 | - |
| 444 | PLUR | Pluri Inc. | 35.28M | -0.85% | 21,370 | 1.34M |
| 445 | GRCE | Grace Therapeutics, Inc. | 34.82M | -3.43% | 519,986 | - |
| 446 | EVAX | Evaxion A/S | 34.70M | -0.24% | 27,312 | 7.53M |
| 447 | BOLD | Boundless Bio, Inc. | 34.52M | 2.67% | 118,788 | - |
| 448 | CRVO | CervoMed Inc. | 34.44M | -1.33% | 23,893 | 4.01M |
| 449 | PTN | Palatin Technologies, Inc. | 32.25M | -16.01% | 30,549 | 8.96M |
| 450 | QNTM | Quantum BioPharma Ltd. | 30.12M | 5.19% | 155,481 | - |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 29.99M | -0.72% | 122,734 | 22.00K |
| 452 | APLM | Apollomics, Inc. | 29.71M | -7.66% | 2,282 | 8.84M |
| 453 | LSTA | Lisata Therapeutics, Inc. | 29.63M | 0.61% | 29,068 | 170.00K |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.48M | 2.45% | 87,539 | - |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 29.43M | -0.06% | 106,329 | - |
| 456 | IGC | IGC Pharma, Inc. | 29.24M | -0.17% | 228,371 | 1.11M |
| 457 | SKYE | Skye Bioscience, Inc. | 28.79M | 0.76% | 245,807 | - |
| 458 | PLRZ | Polyrizon Ltd. | 28.41M | 1.13% | 29,205 | - |
| 459 | HOWL | Werewolf Therapeutics, Inc. | 28.38M | -7.61% | 1,179,220 | 1.14M |
| 460 | KYNB | Kyntra Bio, Inc. | 28.34M | -3.18% | 9,527 | 7.44M |
| 461 | SNSE | Sensei Biotherapeutics, Inc. | 28.25M | 0.38% | 39,182 | - |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 28.19M | -2.87% | 12,350 | - |
| 463 | LTRN | Lantern Pharma Inc. | 28.13M | 21.84% | 912,577 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 27.78M | -2.84% | 11,984 | 14.97M |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 26.85M | 1.01% | 21,192 | 14.99M |
| 466 | ABVC | ABVC BioPharma, Inc. | 26.44M | 1.90% | 96,713 | 797.92K |
| 467 | TPST | Tempest Therapeutics, Inc. | 26.39M | -4.17% | 109,407 | - |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 25.98M | 5.49% | 865,900 | 789.00K |
| 469 | DYAI | Dyadic International, Inc. | 25.89M | -1.70% | 124,589 | 3.09M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.76M | 0.83% | 264,444 | - |
| 471 | OTLK | Outlook Therapeutics, Inc. | 24.06M | -5.15% | 2,212,532 | 205.70K |
| 472 | MRKR | Marker Therapeutics, Inc. | 23.84M | -0.69% | 53,260 | 3.55M |
| 473 | ALLR | Allarity Therapeutics, Inc. | 23.81M | 1.32% | 99,150 | 320.00K |
| 474 | SER | Serina Therapeutics, Inc. | 23.24M | -4.29% | 81,892 | 130.00K |
| 475 | CELU | Celularity Inc. | 22.68M | 1.30% | 295,802 | 26.55M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.33M | 1.53% | 278,188 | 570.00K |
| 477 | LGVN | Longeveron Inc. | 22.11M | 0.65% | 446,356 | 1.20M |
| 478 | AEON | AEON Biopharma, Inc. | 21.57M | -6.82% | 162,111 | - |
| 479 | GRDX | GridAI Technologies Corp. | 21.39M | 2.99% | 60,457 | - |
| 480 | OSRH | OSR Holdings, Inc. | 20.42M | -3.97% | 2,019,683 | 2.91M |
| 481 | XCUR | Exicure, Inc. | 20.01M | -3.09% | 11,529 | 500.00K |
| 482 | CRIS | Curis, Inc. | 19.99M | -9.16% | 597,771 | 7.06M |
| 483 | QNCX | Quince Therapeutics, Inc. | 19.89M | -3.17% | 515,123 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 19.58M | 0.63% | 33,118 | - |
| 485 | LPCN | Lipocine Inc. | 18.62M | -0.43% | 37,804 | 2.00M |
| 486 | ICU | SeaStar Medical Holding Corporation | 18.39M | -4.96% | 73,793 | 1.23M |
| 487 | PASG | Passage Bio, Inc. | 17.71M | 9.74% | 97,025 | - |
| 488 | COCP | Cocrystal Pharma, Inc. | 17.65M | -2.29% | 90,165 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 17.62M | 6.04% | 719,142 | 3.94M |
| 490 | TRAW | Traws Pharma, Inc. | 17.47M | 2.38% | 1,299,680 | 2.79M |
| 491 | NCEL | NewcelX Ltd. | 17.44M | -2.71% | 8,627 | - |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 16.35M | 2.31% | 43,151 | - |
| 493 | INAB | IN8bio, Inc. | 15.66M | -0.63% | 16,205 | - |
| 494 | TOVX | Theriva Biologics, Inc. | 15.14M | 2.52% | 1,548,038 | 300.00K |
| 495 | LEXX | Lexaria Bioscience Corp. | 14.93M | 4.44% | 192,965 | 368.00K |
| 496 | ERNA | Ernexa Therapeutics Inc. | 14.16M | 1.08% | 1,781,916 | 1,000.00 |
| 497 | GNTA | Genenta Science S.p.A. | 13.84M | -4.27% | 59,585 | - |
| 498 | HIND | Vyome Holdings, Inc. | 13.48M | -3.03% | 36,396 | 152.72K |
| 499 | BLRX | BioLineRx Ltd. | 13.43M | 0.64% | 16,039 | 1.18M |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.23M | -1.57% | 143,549 | 1.99M |